128 related articles for article (PubMed ID: 8580276)
21. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
[TBL] [Abstract][Full Text] [Related]
22. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease.
Kusugami K; Matsuura T; West GA; Youngman KR; Rachmilewitz D; Fiocchi C
Gastroenterology; 1991 Dec; 101(6):1594-605. PubMed ID: 1683326
[TBL] [Abstract][Full Text] [Related]
23. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.
MacDonald TT; Hutchings P; Choy MY; Murch S; Cooke A
Clin Exp Immunol; 1990 Aug; 81(2):301-5. PubMed ID: 2117510
[TBL] [Abstract][Full Text] [Related]
24. Mucosal interleukin-6 secretion in ulcerative colitis. Effects of anti-inflammatory drugs and T-cell stimulation.
Jones SC; Crabtree JE; Rembacken BJ; Dixon MF; Trejdosiewicz LK; Whicher JT; Axon AT
Scand J Gastroenterol; 1994 Aug; 29(8):722-8. PubMed ID: 7973432
[TBL] [Abstract][Full Text] [Related]
25. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
[TBL] [Abstract][Full Text] [Related]
26. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease.
Kugathasan S; Saubermann LJ; Smith L; Kou D; Itoh J; Binion DG; Levine AD; Blumberg RS; Fiocchi C
Gut; 2007 Dec; 56(12):1696-705. PubMed ID: 17682002
[TBL] [Abstract][Full Text] [Related]
27. The role of interferon gamma in the pathogenesis of Crohn's disease.
Sasaki T; Hiwatashi N; Yamazaki H; Noguchi M; Toyota T
Gastroenterol Jpn; 1992 Feb; 27(1):29-36. PubMed ID: 1555746
[TBL] [Abstract][Full Text] [Related]
28. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
[TBL] [Abstract][Full Text] [Related]
30. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease.
Hyams JS; Fitzgerald JE; Wyzga N; Muller R; Treem WR; Justinich CJ; Kreutzer DL
J Pediatr Gastroenterol Nutr; 1995 Nov; 21(4):419-25. PubMed ID: 8583293
[TBL] [Abstract][Full Text] [Related]
31. Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells.
Fais S; Capobianchi MR; Silvestri M; Mercuri F; Pallone F; Dianzani F
J Interferon Res; 1994 Oct; 14(5):235-8. PubMed ID: 7861027
[TBL] [Abstract][Full Text] [Related]
32. Infliximab downregulates interferon-gamma production in activated gut T-lymphocytes from patients with Crohn's disease.
Agnholt J; Kaltoft K
Cytokine; 2001 Aug; 15(4):212-22. PubMed ID: 11563881
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
34. Keratinocyte growth factor in inflammatory bowel disease. Increased mRNA transcripts in ulcerative colitis compared with Crohn's disease in biopsies and isolated mucosal myofibroblasts.
Bajaj-Elliott M; Breese E; Poulsom R; Fairclough PD; MacDonald TT
Am J Pathol; 1997 Nov; 151(5):1469-76. PubMed ID: 9358773
[TBL] [Abstract][Full Text] [Related]
35. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
36. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.
ten Hove T; van Montfrans C; Peppelenbosch MP; van Deventer SJ
Gut; 2002 Feb; 50(2):206-11. PubMed ID: 11788561
[TBL] [Abstract][Full Text] [Related]
37. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
38. Dose-effect of interleukin-10 and its immunoregulatory role in Crohn's disease.
Schmit A; Carol M; Robert F; Bontems P; Houben JJ; Van Gossum A; Goldman M; Mascart F
Eur Cytokine Netw; 2002; 13(3):298-305. PubMed ID: 12231473
[TBL] [Abstract][Full Text] [Related]
39. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
[TBL] [Abstract][Full Text] [Related]
40. In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease.
Colpaert S; Vastraelen K; Liu Z; Maerten P; Shen C; Penninckx F; Geboes K; Rutgeerts P; Ceuppens JL
Eur Cytokine Netw; 2002; 13(4):431-7. PubMed ID: 12517728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
